VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in genome-wide association studies: Applied to Alzheimer's disease

It is a grand challenge to reveal the causal effects of DNA variants in complex phenotypes. Although statistical techniques can establish correlations between genotypes and phenotypes in Genome-Wide Association Studies (GWAS), they often fail when the variant is rare. The emerging Network-based Association Studies aim to address this shortcoming in statistical analysis, but are mainly applied to coding variations. Increasing evidences suggest that non-coding variants play critical roles in the etiology of complex diseases. However, few computational tools are available to study the effect of rare non-coding variants on phenotypes. Here we have developed a multiscale modeling variant-to-function-to-network framework VariFunNet to address these challenges. VariFunNet first predict the functional variations of molecular interactions, which result from the non-coding variants. Then we incorporate the genes associated with the functional variation into a tissue-specific gene network, and identify subnetworks that transmit the functional variation to molecular phenotypes. Finally, we quantify the functional implication of the subnetwork, and prioritize the association of the non-coding variants with the phenotype. We have applied VariFunNet to investigating the causal effect of rare non-coding variants on Alzheimer's disease (AD). Among top 21 ranked causal non-coding variants, 16 of them are directly supported by existing evidences. The remaining 5 novel variants dysregulate multiple downstream biological processes, all of which are associated with the pathology of AD. Furthermore, we propose potential new drug targets that may modulate diverse pathways responsible for AD. These findings may shed new light on discovering new biomarkers and therapies for the prevention, diagnosis, and treatment of AD. Our results suggest that multiscale modeling is a potentially powerful approach to studying causal genotype-phenotype associations.

[1]  Euiheon Chung,et al.  Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine , 2013, Molecules and cells.

[2]  K. Giese,et al.  Calcium/calmodulin-dependent kinase II and Alzheimer’s disease , 2015, Molecular Brain.

[3]  Lars Bertram,et al.  Genome-wide association studies in Alzheimer's disease. , 2009, Human molecular genetics.

[4]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[5]  James R. Connor,et al.  HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease , 2014, Front. Pharmacol..

[6]  B. Frey,et al.  Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning , 2015, Nature Biotechnology.

[7]  Zhongming Zhao,et al.  Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology , 2016, Scientific Reports.

[8]  Wei Kong,et al.  The Construction of Common and Specific Significance Subnetworks of Alzheimer's Disease from Multiple Brain Regions , 2015, BioMed research international.

[9]  T. Ideker,et al.  A decade of systems biology. , 2010, Annual review of cell and developmental biology.

[10]  Ralf Herwig,et al.  ConsensusPathDB—a database for integrating human functional interaction networks , 2008, Nucleic Acids Res..

[11]  Diane B. Boivin,et al.  Circadian Clock Gene Expression in Brain Regions of Alzheimer ’s Disease Patients and Control Subjects , 2011, Journal of biological rhythms.

[12]  Gary D. Stormo,et al.  DNA binding sites: representation and discovery , 2000, Bioinform..

[13]  M. Bronner,et al.  Rbms3 functions in craniofacial development by posttranscriptionally modulating TGF-β signaling , 2012, The Journal of cell biology.

[14]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[15]  E. Gehan,et al.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data , 2008, Nature Reviews Cancer.

[16]  Gang Yuan,et al.  Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes , 2015, Journal of Investigative Medicine.

[17]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[18]  Xinsheng Yao,et al.  Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss , 2012, Proceedings of the National Academy of Sciences.

[19]  Joanna M. Wardlaw,et al.  Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936☆ , 2014, Neurobiology of Aging.

[20]  H. Kitano.  A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.

[21]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[22]  Wei Zhang,et al.  Identification of a novel distal regulatory element of the human Neuroglobin gene by the chromosome conformation capture approach , 2016, Nucleic acids research.

[23]  Hanghang Tong,et al.  Make It or Break It: Manipulating Robustness in Large Networks , 2014, SDM.

[24]  Jason H. Moore,et al.  Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans , 2010, Alzheimer's & Dementia.

[25]  James B. Brown,et al.  An overview of recent developments in genomics and associated statistical methods , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[26]  Zheng Zhao,et al.  Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach. , 2016, Journal of medicinal chemistry.

[27]  Enrico Garaci,et al.  HSV-1 and Alzheimer’s disease: more than a hypothesis , 2014, Front. Pharmacol..

[28]  Daniel S. Himmelstein,et al.  Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.

[29]  Jun Tan,et al.  Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.

[30]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[31]  O. Ogunshola,et al.  Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration? , 2009, Cellular and Molecular Life Sciences.

[32]  W. Le,et al.  Pathological role of hypoxia in Alzheimer's disease , 2010, Experimental Neurology.

[33]  P. Spear,et al.  Herpes simplex virus: receptors and ligands for cell entry , 2004, Cellular microbiology.

[34]  Sarah L. Kinnings,et al.  Novel computational approaches to polypharmacology as a means to define responses to individual drugs. , 2012, Annual review of pharmacology and toxicology.

[35]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[36]  Zhong-Xiang Yao,et al.  Modulation of FGF receptor signaling as an intervention and potential therapy for myelin breakdown in Alzheimer's disease. , 2013, Medical hypotheses.

[37]  Hui Yang,et al.  Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR , 2015, Nature Protocols.

[38]  Paul K Crane,et al.  Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. , 2012, Archives of neurology.

[39]  David M Holtzman,et al.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.

[40]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[41]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[42]  Q. Guan,et al.  Gene Expression Profile and Functional Analysis of Alzheimer’s Disease , 2013, American journal of Alzheimer's disease and other dementias.

[43]  Paul M. Thompson,et al.  Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults , 2013, NeuroImage.

[44]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..